Pharmafile Logo
Pharmafocus logo
Advanced Search
Gilenya picture

NICE U-turn sees Gilenya MS pill recommended

March 16, 2012
Sales and Marketing MS, NICE, UK, fingolimod, gilenya

NICE has changed its mind on Novartis’ multiple sclerosis pill Gilenya, and is now recommending the drug in a subgroup …

News

Updated set of mandatory Article 57(2) requirements for marketing authorisation holders

March 15, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

An updated set of mandatory requirements for Marketing Authorisation Holders (MAH) to comply with Article 57(2) of the forthcoming new …

News
Press release

Four new appointments at PAN Advertising

March 15, 2012
Medical Communications, Sales and Marketing Pan Advertising

PAN Advertising has made four new appointments since Jon Linscott took over as managing director in February, with two new …

Appointment

GSK chooses Infosys and Fabric Worldwide for digital platform

March 15, 2012
Medical Communications, Sales and Marketing Fabric Worldwide, GSK, Infosys, digital

GlaxoSmithKline has hired two technology companies to help it optimise digital communications in consumer healthcare and pharmaceuticals.The firm will work …

News

Photodynamic treatment for HPV shows potential

March 15, 2012
Research and Development Cancer, GE Healthcare, HPV, Photocure, ipsen, oncologly

A new photodynamic therapy treatment for human papilloma virus (HPV) associated diseases of the cervix has shown potential in a …

News
Pradaxa image

NICE recommends Pradaxa for stroke prevention

March 15, 2012
Sales and Marketing Boehringer Ingelheim, NICE, Pradaxa, atrial fibrillation

NICE has given a limited recommendation to Boehringer Ingelheim’s blood thinner Pradaxa. The watchdog said in final guidance that Pradaxa …

News

Dismay as Sanofi announces UK plant closure

March 15, 2012
Manufacturing and Production, Sales and Marketing Plavix, Sanofi, job losses, manufacturing

Sanofi has decided to close down a manufacturing facility in the North East of the UK with the loss of …

News

Cmed release Global Strategic and Regulatory Consulting Booklet

March 14, 2012
Research and Development

The regulatory environments within the industry continue to change and vary internationally. Cmed’s regulatory and medical professionals keep track of …

Feature
Press release
White paper

Europe’s pharma sector : living through the crisis

March 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma

Pharmaceutical markets across Europe have been badly hit by the economic crisis, with revenues in some countries being decimated by …

Feature

EMA begins pilot for electronic drug applications

March 14, 2012
Medical Communications EMA, European Medicines Agency, eCTD

The European Medicines Agency has launched a pilot scheme that allows pharma firms to submit new drug applications electronically.  The …

News

Maps and apps: video interviews with healthcare professionals

March 14, 2012
Medical Communications Digital Blog, apps

Last month the Department of Health released ideas for new apps aimed at patients and doctors. Below are some video …

News
Zytiga image

Charity attacks Scottish decision on Zytiga

March 14, 2012
Sales and Marketing Janssen, NICE, PAS, Prostate Cancer Charity, Zytiga

Scotland’s medicines regulator has turned down Janssen’s prostate cancer pill Zytiga, leading to a backlash from charities. The Scottish Medicines …

News
Zelboraf image

Roche’s melanoma pill launched in UK

March 14, 2012
Sales and Marketing BMS, CDF, NICE, Roche, Yervoy, Zelboraf

Roche’s Zelboraf has been launched in the UK to treat the deadliest form of skin cancer.  Zelboraf (vemurafenib) is the …

News
AstraZeneca picture

AstraZeneca sues FDA over generic Seroquel

March 14, 2012
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Seroquel, US, generics

AstraZeneca has said it filed a lawsuit against the US FDA in a bid to block approval of generic versions …

News
Pfizer picture

Pfizer pulls out of $350 million insulin pact

March 14, 2012
Research and Development, Sales and Marketing Biocon, Humalog, Lantus, NovoLog, Pfizer

Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …

News

SHL talks about Autoinjector Development in Manufacturing Chemist’s latest issue

March 14, 2012
Manufacturing and Production auto injector, autoinjector, manufacturing chemist, pen injector, shl group

Manufacturing Chemist, an established publication in the biopharmaceutical industry, recently approached SHL to share with their readers the company’s knowledge …

Feature
Thought Leadership
Merck image

Merck warned over missing Januvia safety study

March 13, 2012
Research and Development FDA, Januvia, Merck, study

Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …

News
Jon Tucker and David Willetts picture

Science minister opens new Pfizer facility in Havant

March 13, 2012
Manufacturing and Production Havant, Pfizer, R&D, Tucker, Willetts

Science minister David Willetts has opened Pfizer’s new state-of-the-art cold storage facility at its site in Havant.  The new £7 …

News

Catalent continues investment in Global Clinical Supply services with German warehousing & controlled substance expansion

March 13, 2012
Research and Development

Somerset, NJ – March 7, 2012 — Catalent Pharma Solutions announced the completion of extended warehousing facilities in Schorndorf, Germany …

News
Press release

Catalent Expert Presents on Protein Expression in CHO Cells: Comparison of GPEx® Technology to Traditional Cell Line Engineering at Cell Culture World Congress 2012

March 13, 2012
Research and Development

Somerset, NJ February 21, 2012 — Michael Jenkins, Ph.D., General Manager of Catalent Pharma Solutions’ Middleton, WI facility, will present …

News
Press release
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026